glycolaldehyde has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes Kjerulf, D | 1 |
| Wang, S | 1 |
| Omer, M | 1 |
| Pathak, A | 1 |
| Subramanian, S | 1 |
| Han, CY | 1 |
| Tang, C | 1 |
| den Hartigh, LJ | 1 |
| Shao, B | 1 |
| Chait, A | 1 |
1 other study available for glycolaldehyde and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects.
Topics: Acetaldehyde; Apolipoprotein A-I; Apolipoprotein A-II; Cholesterol; Diabetes Mellitus, Type 1; Gluco | 2020 |